MediciNova Statistics

Total Valuation

MediciNova has a market cap or net worth of $63.76 million. The enterprise value is $27.54 million.

Market Cap	63.76M
Enterprise Value	27.54M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

MediciNova has 49.05 million shares outstanding.

Current Share Class	49.05M
Shares Outstanding	49.05M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.98%
Owned by Institutions (%)	10.64%
Float	42.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.25
P/TBV Ratio	1.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.66, with a Debt / Equity ratio of 0.01.

Current Ratio	17.66
Quick Ratio	17.14
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -20.33% and return on invested capital (ROIC) is -14.39%.

Return on Equity (ROE)	-20.33%
Return on Assets (ROA)	-13.81%
Return on Invested Capital (ROIC)	-14.39%
Return on Capital Employed (ROCE)	-25.33%
Revenue Per Employee	n/a
Profits Per Employee	-$858,396
Employee Count	13
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, MediciNova has paid $5,537 in taxes.

Income Tax	5,537
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.09% in the last 52 weeks. The beta is 0.41, so MediciNova's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	-9.09%
50-Day Moving Average	1.42
200-Day Moving Average	1.72
Relative Strength Index (RSI)	45.64
Average Volume (20 Days)	13,000

Short Selling Information

The latest short interest is 162,870, so 0.33% of the outstanding shares have been sold short.

Short Interest	162,870
Short Previous Month	166,507
Short % of Shares Out	0.33%
Short % of Float	0.39%
Short Ratio (days to cover)	12.33

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.74M
Pretax Income	-8.16M
Net Income	-11.16M
EBITDA	-12.72M
EBIT	-12.74M
Earnings Per Share (EPS)	-$0.23

Full Income Statement

Balance Sheet

The company has $36.57 million in cash and $355,058 in debt, giving a net cash position of $36.22 million or $0.74 per share.

Cash & Cash Equivalents	36.57M
Total Debt	355,058
Net Cash	36.22M
Net Cash Per Share	$0.74
Equity (Book Value)	49.93M
Book Value Per Share	1.02
Working Capital	35.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$10.56 million and capital expenditures -$895, giving a free cash flow of -$10.56 million.

Operating Cash Flow	-10.56M
Capital Expenditures	-895
Free Cash Flow	-10.56M
FCF Per Share	-$0.22

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MediciNova does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-17.50%
FCF Yield	-16.56%

Analyst Forecast

The average price target for MediciNova is $7.00, which is 438.46% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	438.46%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-22.94%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1